MedicarePartD.guide

A non-government resource built from CMS public data

TYENNE 162 mg/.9mL Injection, Solution

Also known as Tocilizumab-Aazg. Coverage in Puerto Rico (CMS PDP Region 38).

3 of 3 stand-alone Part D plans in Puerto Rico cover this drug on tier 5.

3 of 3 plans apply a prior authorization, step therapy or quantity limit.

40 Medicare Advantage plans in PR do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. PR: 40 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
HealthSpring Extra Rx (PDP)$50.00/mo premium · $615.00 deductible5Specialty Tier25%—$808.5569$3,234.234 units
  • Prior authorization
  • Quantity limit 3.6 per 28 days
HealthSpring Assurance Rx (PDP)$65.70/mo premium · $615.00 deductible5Specialty Tier25%—$808.6660$3,234.664 units
  • Prior authorization
  • Quantity limit 3.6 per 28 days
AARP Medicare Rx Preferred from UHC (PDP)$145.10/mo premium · $615.00 deductible5Specialty Tier25%25%$886.1230$3,544.494 units
  • Prior authorization
  • Quantity limit 3.6 per 28 days

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →